{
    "2019-10-24": [
        [
            {
                "time": "",
                "original_text": "沃森生物：上市品种持续增长，新品有望年内上市",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "上市品种",
                        "新品",
                        "年内上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物前三季扣非净利同比增9成，13价肺炎疫苗进入审批尾声",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "前三季",
                        "扣非净利",
                        "同比增9成",
                        "13价肺炎疫苗",
                        "审批尾声"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：新品有望年内上市 谨慎增持评级",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新品",
                        "年内上市",
                        "谨慎增持评级"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}